NEUVOGEN Revenue

Biotechnology Research • San Diego, California, United States • 11-20 Employees

NEUVOGEN revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	No funding

Key Contacts at NEUVOGEN

John Moscariello

Chief Technology Officer

Jordan M. Greenberg

Associate Director, Msat

Rebecca Garcia

Associate Director

Company overview

Headquarters	11095 Flintkote Avenue, Suite C, San Diego, CA 92121, US
Website	neuvogen.com
NAICS	541714
Keywords	Biotechnology, Research, Innovation, Cancer, Solid Tumor, Systems Approach, Immunoncology, Transformative Therapies, Whole Cell Cancer Vaccines
Employees	11-20
Socials

NEUVOGEN Email Formats

NEUVOGEN uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@neuvogen.com), used 55% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@neuvogen.com	65%
{first name}{last name}	johndoe@neuvogen.com	35%

About NEUVOGEN

NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated. Our mission is to serve patients with cancer by developing transformative therapies to meaningfully extend their lives. NEUVOGEN’s vision is to revolutionize cancer treatment by harnessing the full power of a patient’s immune system to eliminate cancer from their body. We have taken a fundamentally different approach to solving cancer. Unlike other early-stage immunoncology companies, we try to solve for multiple issues arising from the complexity of cancer biology. Our approach to solving cancer is based on the concept that in order to fully address the complexity of solid tumor cancer biology, many targets and multiple biologic pathways need to be addressed simultaneously. NEUVOGEN is advancing a broad pipeline of therapeutic whole cell cancer vaccine candidates designed to activate the patient’s immune system to target and eliminate existing tumors and prevent future metastases. Our research programs focus on therapeutic cancer vaccines to treat a wide range of tumor types across numerous solid tumor indications.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

NEUVOGEN has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

NEUVOGEN has never raised funding before.

NEUVOGEN Tech Stack

Discover the technologies and tools that power NEUVOGEN's digital infrastructure, from frameworks to analytics platforms.

Slick

JavaScript libraries

WPForms

Form builders

Google Maps

Maps

Animate.css

UI frameworks

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Frequently asked questions

NEUVOGEN is located in San Diego, California, US.

NEUVOGEN generates an estimated annual revenue of $1,711,100. This revenue figure reflects the company's market position and business performance in its industry.

NEUVOGEN has an estimated valuation of $5,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NEUVOGEN has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at NEUVOGEN

John Moscariello

Chief Technology Officer

Jordan M. Greenberg

Associate Director, Msat

Rebecca Garcia

Associate Director

4.8

40,000 users